PTC Therapeutics, Inc. (PTCT)

Nasdaq Health Care Pharmaceuticals S&P SmallCap 600

$65.44

-0.23 (-0.35%)

Close of Nov 06, 2026 · end-of-day data

Source: PTC Therapeutics, Inc.'s 10-K / 10-Q XBRL data on SEC EDGAR · fetched Nov 06, 2026

Revenue, net income & free cash flow

Income statement

fiscal years · USD

Fiscal year	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$82.70M	$194.39M	$264.73M	$306.98M	$380.77M	$538.59M	$698.80M	$937.82M	$806.78M	$1.73B
Cost of revenue	$0	$4.58M	$12.67M	$12.13M	—	—	—	—	—	—
Gross profit	$82.70M	$189.81M	$252.06M	$294.85M	—	—	—	—	—	—
Research & development	$117.63M	$117.46M	$171.98M	$257.45M	$477.64M	$540.68M	$651.50M	$666.56M	$534.48M	$455.25M
Selling, general & admin	$97.13M	$121.27M	$153.55M	$202.54M	$245.16M	$285.77M	$326.00M	$332.54M	$300.91M	$347.14M
Operating income	-$132.06M	-$64.29M	-$115.69M	-$241.16M	-$431.77M	-$374.44M	-$447.41M	-$439.50M	-$302.57M	$866.93M
Pre-tax income	-$141.54M	-$77.67M	-$128.11M	-$239.93M	-$402.93M	-$518.34M	-$587.49M	-$696.11M	-$363.12M	$696.62M
Income tax	$569.00K	$1.33M	-$29.00K	$11.65M	$35.23M	$5.56M	-$28.47M	-$69.51M	$176.00K	$13.97M
Net income	-$142.11M	-$79.00M	-$128.08M	-$251.58M	-$438.16M	-$523.90M	-$559.02M	-$626.60M	-$363.30M	$682.64M
EBITDA	-$128.77M	-$46.61M	-$89.60M	-$208.98M	-$388.28M	-$310.31M	-$318.57M	-$202.91M	-$226.91M	$905.75M
EPS (basic)	$-4.17	$-2.02	$-2.75	$-4.27	$-6.64	$-7.43	$-7.79	$-8.37	$-4.73	$8.58
EPS (diluted)	$-4.17	$-2.02	$-2.75	$-4.27	$-6.64	$-7.43	$-7.79	$-8.37	$-4.73	$7.78
Diluted shares	34.04M	39.18M	46.58M	58.86M	66.03M	70.47M	71.73M	74.84M	76.85M	88.31M
Gross margin	100.0%	97.6%	95.2%	96.0%	—	—	—	—	—	—
Operating margin	-159.7%	-33.1%	-43.7%	-78.6%	-113.4%	-69.5%	-64.0%	-46.9%	-37.5%	50.1%
Net margin	-171.8%	-40.6%	-48.4%	-82.0%	-115.1%	-97.3%	-80.0%	-66.8%	-45.0%	39.4%

Balance sheet

fiscal years · USD

Fiscal year	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash & equivalents	$58.32M	$111.79M	$169.50M	$288.03M	$208.81M	$189.72M	$279.83M	$594.00M	$779.71M	$984.65M
Short-term investments	$173.34M	$79.45M	$58.09M	$398.54M	$894.84M	$583.66M	$130.87M	$282.74M	$359.99M	$960.72M
Receivables	$24.93M	$40.39M	$67.91M	$55.54M	$69.93M	$110.45M	$155.61M	$160.82M	$158.55M	$181.62M
Inventory	$0	$10.75M	$16.12M	$19.29M	$18.70M	$15.86M	$21.81M	$30.58M	$23.19M	$79.65M
Total current assets	$261.29M	$249.06M	$320.86M	$779.28M	$1.23B	$954.37M	$693.78M	$1.22B	$1.37B	$2.27B
Goodwill	—	$0	$82.34M	$82.34M	$82.34M	$82.34M	$82.34M	$82.34M	$82.34M	$82.34M
Total assets	$269.35M	$391.65M	$1.12B	$1.62B	$2.21B	$1.94B	$1.71B	$1.90B	$1.71B	$2.90B
Total current liabilities	$49.62M	$82.05M	$166.80M	$235.86M	$277.33M	$509.35M	$406.24M	$603.10M	$580.98M	$968.43M
Short-term debt	—	$0	$11.67M	$20.00M	—	$149.54M	—	—	—	$286.63M
Long-term debt	$98.22M	$144.97M	$141.35M	$293.86M	$309.14M	$281.89M	$571.72M	$284.21M	$285.41M	—
Total debt	$98.22M	$144.97M	$153.01M	$313.86M	$309.14M	$431.43M	$571.72M	$284.21M	$285.41M	$286.63M
Total liabilities	$149.76M	$235.22M	$768.50M	$1.03B	$1.73B	$1.94B	$2.05B	$2.71B	$2.80B	$3.10B
Shareholders' equity	$119.58M	$156.44M	$350.73M	$594.33M	$481.98M	$1.44M	-$347.09M	-$818.55M	-$1.10B	-$205.31M

Cash flow

fiscal years · USD

Fiscal year	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Operating cash flow	-$103.57M	-$10.06M	-$27.64M	-$98.64M	-$194.07M	-$251.33M	-$356.65M	-$158.42M	-$107.69M	$711.20M
Capital expenditures	$1.78M	$3.10M	$7.10M	$13.76M	$17.84M	$28.21M	$32.02M	$28.44M	$6.50M	$8.86M
Free cash flow	-$105.34M	-$13.16M	-$34.74M	-$112.40M	-$211.91M	-$279.55M	-$388.67M	-$186.86M	-$114.19M	$702.34M
Investing cash flow	$104.48M	$13.12M	-$42.61M	-$387.24M	-$561.55M	$219.18M	$290.18M	-$176.74M	$44.18M	-$861.98M
Financing cash flow	$968.00K	$44.22M	$131.57M	$613.21M	$668.72M	$20.88M	$167.95M	$646.40M	$255.87M	$331.09M
Stock-based compensation	$35.01M	$30.56M	$33.25M	$42.13M	$70.33M	$103.51M	$110.33M	$101.64M	$74.61M	$74.55M
Depreciation & amortization	$3.29M	$17.68M	$26.09M	$32.18M	$43.49M	$64.13M	$128.84M	$236.59M	$75.66M	$38.81M

Income statement

quarters · USD

Quarter ended	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Revenue	$307.06M	$210.12M	$186.70M	$196.79M	$213.17M	$1.18B	$178.88M	$211.01M	$164.68M	$272.55M	$360.52M	$357.81M
Research & development	$121.35M	$116.13M	$132.17M	$161.41M	$124.77M	$108.97M	$112.99M	$100.16M	$133.13M	$100.87M	$99.15M	$105.35M
Selling, general & admin	$76.29M	$73.27M	$69.50M	$73.46M	$84.68M	$80.96M	$85.26M	$84.05M	$96.87M	$86.18M	$80.63M	$80.08M
Operating income	$5.82M	-$45.45M	-$40.22M	-$54.51M	-$162.39M	$970.23M	-$34.96M	$3.02M	-$71.35M	$44.96M	$148.98M	$25.11M
Pre-tax income	-$157.05M	-$84.70M	-$85.73M	-$97.99M	-$94.70M	$929.83M	-$71.05M	-$23.07M	-$139.08M	-$2.46M	$97.55M	-$41.09M
Income tax	-$1.26M	$6.88M	$13.45M	$8.66M	-$28.81M	$63.27M	-$6.20M	-$38.97M	-$4.12M	$347.00K	$14.05M	$10.61M
Net income	-$155.79M	-$91.58M	-$99.18M	-$106.65M	-$65.89M	$866.56M	-$64.85M	$15.90M	-$134.97M	-$2.81M	$83.50M	-$51.69M
EBITDA	$86.53M	$9.94M	-$33.20M	-$48.02M	-$155.62M	$977.45M	-$27.37M	$14.12M	-$58.45M	$60.37M	$164.85M	$41.93M
EPS (basic)	$-2.06	$-1.20	$-1.29	$-1.39	$-0.85	$11.09	$-0.83	$0.20	$-1.82	$-0.03	$1.01	$-0.62
EPS (diluted)	$-2.06	$-1.20	$-1.29	$-1.39	$-0.85	$10.04	$-0.83	$0.20	$-1.67	$-0.03	$0.92	$-0.62
Diluted shares	219.68K	76.50M	76.73M	76.93M	128.72K	86.39M	78.15M	87.12M	1.41M	82.52M	92.02M	83.48M
Operating margin	1.9%	-21.6%	-21.5%	-27.7%	-76.2%	82.5%	-19.5%	1.4%	-43.3%	16.5%	41.3%	7.0%
Net margin	-50.7%	-43.6%	-53.1%	-54.2%	-30.9%	73.7%	-36.3%	7.5%	-82.0%	-1.0%	23.2%	-14.4%

Balance sheet

quarters · USD

Quarter ended	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Cash & equivalents	$594.00M	$548.36M	$654.78M	$526.00M	$779.71M	$1.48B	$1.02B	$672.62M	$984.65M	$833.99M	$1.05B	$508.89M
Short-term investments	$282.74M	$336.46M	$438.51M	$487.36M	$359.99M	$546.95M	$971.76M	$1.02B	$960.72M	$1.06B	$1.18B	$1.62B
Receivables	$160.82M	$197.66M	$187.15M	$199.98M	$158.55M	$210.50M	$196.13M	$203.07M	$181.62M	$219.92M	$239.04M	$238.07M
Inventory	$30.58M	$30.06M	$31.83M	$35.67M	$23.19M	$21.68M	$34.06M	$52.69M	$79.65M	$75.57M	$91.35M	$109.33M
Total current assets	$1.22B	$1.17B	$1.36B	$1.28B	$1.37B	$2.32B	$2.27B	$2.01B	$2.27B	$2.25B	$2.62B	$2.54B
Goodwill	$82.34M	$82.34M	$82.34M	$82.34M	$82.34M	$82.34M	$82.34M	$82.34M	$82.34M	$82.34M	$82.34M	$82.34M
Total assets	$1.90B	$1.79B	$1.92B	$1.84B	$1.71B	$2.66B	$2.63B	$2.64B	$2.90B	$2.87B	$3.25B	$3.21B
Total current liabilities	$603.10M	$574.55M	$609.80M	$610.71M	$580.98M	$595.39M	$627.81M	$866.25M	$968.43M	$923.60M	$771.07M	$776.08M
Short-term debt	—	—	—	—	—	—	—	$286.32M	$286.63M	$286.94M	$55.45M	—
Long-term debt	$284.21M	$284.51M	$284.81M	$285.11M	$285.41M	$285.71M	$286.01M	—	—	—	$535.52M	$536.27M
Total debt	$284.21M	$284.51M	$284.81M	$285.11M	$285.41M	$285.71M	$286.01M	$286.32M	$286.63M	$286.94M	$590.97M	$536.27M
Total liabilities	$2.71B	$2.68B	$2.90B	$2.90B	$2.80B	$2.84B	$2.84B	$2.80B	$3.10B	$3.05B	$3.42B	$3.40B
Shareholders' equity	-$818.55M	-$893.92M	-$980.18M	-$1.05B	-$1.10B	-$185.76M	-$206.55M	-$155.76M	-$205.31M	-$180.47M	-$165.36M	-$191.21M

Cash flow

quarters · USD

Quarter ended	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Operating cash flow	-$100.29M	$70.76M	-$71.45M	-$76.99M	-$30.00M	$870.10M	-$58.33M	-$66.30M	-$34.27M	-$59.04M	$129.11M	-$25.31M
Capital expenditures	$5.57M	$9.59M	-$7.38M	$522.00K	$3.77M	$1.72M	$1.25M	$3.52M	$2.37M	$1.20M	$2.19M	$2.66M
Free cash flow	-$105.85M	$61.17M	-$78.83M	-$77.51M	-$33.77M	$868.38M	-$59.58M	-$69.82M	-$36.65M	-$60.24M	$126.92M	-$27.97M
Investing cash flow	-$94.42M	-$114.93M	-$65.92M	-$42.67M	$267.71M	-$184.36M	-$422.01M	-$289.62M	$34.01M	-$93.74M	-$122.56M	-$442.41M
Financing cash flow	$620.49M	$540.00K	$246.48M	-$17.63M	$26.47M	$9.41M	$3.96M	$15.22M	$302.50M	$6.40M	$211.88M	-$73.24M
Stock-based compensation	$16.51M	$18.38M	$19.24M	$19.75M	$17.24M	$18.06M	$18.54M	$19.43M	$18.52M	$23.42M	$23.29M	$23.83M
Depreciation & amortization	$80.70M	$55.40M	$7.02M	$6.49M	$6.76M	$7.22M	$7.58M	$11.11M	$12.90M	$15.41M	$15.87M	$16.82M

Quarterly figures are rebuilt from the year-to-date totals companies report — Q4 is the full year minus the first nine months, since no 10-Q is filed for it. Values are as filed; later restatements replace earlier ones. Fiscal years are labelled by the calendar year in which they end.